Literature DB >> 6122506

The calmodulin hypothesis of neurotransmission.

R J DeLorenzo.   

Abstract

Ca2+ plays a major role in neurotransmission and synaptic modulation. Evidence is presented to support the calmodulin hypothesis of neurotransmission developed in this laboratory stating that calmodulin, a major Ca2+ binding protein in brain, mediates the effects of Ca2+ on neurotransmission. Calmodulin was isolated from highly enriched preparations of synaptic vesicles and nerve terminal cytoplasm. Ca2+ and calmodulin were shown to regulate several synaptic processes in isolated and intact preparations, including endogenous synaptic Ca2+-calmodulin protein kinase activity, neurotransmitter release, and synaptic vesicle and synaptic membrane interactions. Ca2+ and calmodulin were shown to activate a synaptic tubulin kinase system which was shown to be a distinct enzyme system from the cyclic AMP protein kinase. Ca2+ and calmodulin stimulated phosphorylation of tubulin altered the properties of tubulin, forming insoluble tubulin fibrils. Evidence for the role of Ca2+-calmodulin kinase activity, especially the calmodulin-tubulin kinase, in neurotransmission are presented. The effects of several neuroactive drugs on the synaptic calmodulin system are presented. The results support the hypothesis that calmodulin mediates many of calcium's actions at the synapse, and that the effects of Ca2+ on synaptic protein phosphorylation, especially synaptic tubulin, may provide a biochemical mechanism for converting the Ca2+ signal into a motor force in the process of neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6122506     DOI: 10.1016/0143-4160(81)90026-9

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  24 in total

1.  Calmodulin suppresses synaptotagmin-2 transcription in cortical neurons.

Authors:  Zhiping P Pang; Wei Xu; Peng Cao; Thomas C Südhof
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 2.  The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release.

Authors:  P J Robinson
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Role of calcium channels in effects of antidepressant drugs on responsiveness to pain.

Authors:  L Antkiewicz-Michaluk; I Romańska; J Michaluk; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 4.  Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis.

Authors:  Nisha Nagarkatti; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Expert Rev Neurother       Date:  2009-06       Impact factor: 4.618

5.  The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.

Authors:  H Wiegand; H Lohmann; S V Chandra
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

6.  Modulation of calcium-mediated inactivation of ionic currents by Ca2+/calmodulin-dependent protein kinase II.

Authors:  M Sakakibara; D L Alkon; R DeLorenzo; J R Goldenring; J T Neary; E Heldman
Journal:  Biophys J       Date:  1986-08       Impact factor: 4.033

7.  Ca2+-dependent phosphorylation by endogenous kinases of Mr 95 K and 50 K-55 K proteins in PC12 pheochromocytoma cells.

Authors:  K Okumura-Noji; T Kato; R Tanaka
Journal:  Neurochem Res       Date:  1986-11       Impact factor: 3.996

8.  Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations.

Authors:  W C Taft; R J DeLorenzo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Evidence that M1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C.

Authors:  M Costa; M Barrington; H Majewski
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Calmodulin modulates Akt activity in human breast cancer cell lines.

Authors:  Christine M Coticchia; Chetana M Revankar; Tushar B Deb; Robert B Dickson; Michael D Johnson
Journal:  Breast Cancer Res Treat       Date:  2008-06-28       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.